Asthma
Clinical research study trial for adolescents aged 12 to 17 years with inadequately controlled asthma. It compares a once-daily single-inhaler triple therapy (fluticasone furoate/umeclidinium bromide/vilanterol) with a once-daily single-inhaler double therapy (fluticasone furoate/vilanterol). The study aims to evaluate lung function improvements and safety over a 24-week treatment period.
Migraine
This migraine clinical trial is for children and teenagers aged 6-17 who have been diagnosed with migraines for at least six months, experience migraines on six or more days per month, and have attacks lasting 4 to 72 hours when untreated. The study aims to evaluate a potential preventive treatment over an initial six-month period, with an option for extended participation.
Eczema
We are always looking for candidates for eczema clinical trials. Our studies aim to evaluate new treatments for eczema, focusing on effectiveness, safety, and improving quality of life. If you have eczema and are interested in participating, contact us to see if you qualify.